GL1X · GenesisL1 explorer

MolNFT v1 · #100448 · protein

Human src A403T mutant bound to kinase inhibitor bosutinib

4MXX · Proto-oncogene tyrosine-protein kinase src: “Human src A403T mutant bound to kinase inhibitor bosutinib”. X-ray diffraction, 1 ligand (DB8), 3 pockets (best druggability 0.69). MolNFT v1 #100448 on GenesisL1: 3D structure, binding…

PDB
4MXX
Type
protein
Length
526 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proto-oncogene tyrosine-protein kinase src
EC
2.7.10.2
UniProt
P12931
Ligands
DB8
Pockets
3 · best druggability 0.69

Structure

x-ray diffraction · 2 distinct chains · 40% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein26640% helix, 18% strandP12931
BProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein26040% helix, 17% strandP12931

Ligands and binding sites

  • DB8 · 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17850.690.7675DB8
23870.610.7754empty
32700.610.8029DB8

Interfaces

1 interface between chains.

  • A–B · 385 Ų buried · 5 hydrogen bonds · protein-protein

Compared structures

  • 4MXX · Human Src A403T mutant bound to kinase inhibitor bosutinib · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.